Cargando…

Rapid Molecular Testing for TB to Guide Respiratory Isolation in the U.S.: A Cost-Benefit Analysis

BACKGROUND: Respiratory isolation of inpatients during evaluation for TB is a slow and costly process in low-burden settings. Xpert MTB/RIF (Xpert) is a novel molecular test for tuberculosis (TB) that is faster and more sensitive but substantially more expensive than smear microscopy. No previous st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Millman, Alexander J., Dowdy, David W., Miller, Cecily R., Brownell, Robert, Metcalfe, John Z., Cattamanchi, Adithya, Davis, J. Lucian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835836/ https://www.ncbi.nlm.nih.gov/pubmed/24278155 http://dx.doi.org/10.1371/journal.pone.0079669

Ejemplares similares

A Transcriptional Signature for Active TB: Have We Found the Needle in the Haystack?
por: Cattamanchi, Adithya, et al.
Publicado: (2013)

Tuberculosis progression rates in U.S. Immigrants following screening with interferon-gamma release assays
por: Blount, Robert J., et al.
Publicado: (2016)

Nucleic Acid Amplification Tests for Diagnosis of Smear-Negative TB in a High HIV-Prevalence Setting: A Prospective Cohort Study
por: Davis, J. Lucian, et al.
Publicado: (2011)

Serial testing for latent tuberculosis using QuantiFERON-TB Gold In-Tube: A Markov model
por: Moses, Mark W., et al.
Publicado: (2016)

mHealth to improve implementation of TB contact investigation: a case study from Uganda
por: Gupta, Amanda J., et al.
Publicado: (2023)

Population-Level Impact of Same-Day Microscopy and Xpert MTB/RIF for Tuberculosis Diagnosis in Africa
por: Dowdy, David W., et al.
Publicado: (2013)

Cost-effectiveness of triage testing for facility-based systematic screening of tuberculosis among Ugandan adults
por: Murray, Matthew, et al.
Publicado: (2016)

Health worker perspectives on barriers to delivery of routine tuberculosis diagnostic evaluation services in Uganda: a qualitative study to guide clinic-based interventions
por: Cattamanchi, Adithya, et al.
Publicado: (2015)

Where will it end? Pathways to care and catastrophic costs following negative TB evaluation in Uganda
por: Samuels, Thomas H. A., et al.
Publicado: (2021)

Theory-Informed Design of a Tailored Strategy for Implementing Household TB Contact Investigation in Uganda
por: Davis, J. Lucian, et al.
Publicado: (2022)

Sensitivity of direct versus concentrated sputum smear microscopy in HIV-infected patients suspected of having pulmonary tuberculosis
por: Cattamanchi, Adithya, et al.
Publicado: (2009)

Theory-Informed Interventions to Improve the Quality of Tuberculosis Evaluation at Ugandan Health Centers: A Quasi-Experimental Study
por: Chaisson, Lelia H., et al.
Publicado: (2015)

Diagnostic accuracy of TB-LAMP for pulmonary tuberculosis: a systematic review and meta-analysis
por: Shete, Priya B., et al.
Publicado: (2019)

Is Scale-Up Worth It? Challenges in Economic Analysis of Diagnostic Tests for Tuberculosis
por: Dowdy, David W., et al.
Publicado: (2011)

Bronchoalveolar Lavage Enzyme-Linked Immunospot for Diagnosis of Smear-Negative Tuberculosis in HIV-Infected Patients
por: Cattamanchi, Adithya, et al.
Publicado: (2012)

Scaling Up TB Screening and TB Preventive Treatment Globally: Key Actions and Healthcare Service Costs
por: Satyanarayana, Srinath, et al.
Publicado: (2023)

Empiric treatment of pulmonary TB in the Xpert era: Correspondence of sputum culture, Xpert MTB/RIF, and clinical diagnoses
por: Kendall, Emily A., et al.
Publicado: (2019)

An Analysis of Costs and Health Co-Benefits for a U.S. Power Plant Carbon Standard
por: Buonocore, Jonathan J., et al.
Publicado: (2016)

Study protocol: a cluster randomized trial to evaluate the effectiveness and implementation of onsite GeneXpert testing at community health centers in Uganda (XPEL-TB)
por: Reza, Tania F., et al.
Publicado: (2020)

Correction: An Analysis of Costs and Health Co-Benefits for a U.S. Power Plant Carbon Standard
por: Buonocore, Jonathan J., et al.
Publicado: (2016)

Validating novel diagnostic assays for tuberculosis in the context of existing tools
por: Kerkhoff, Andrew D, et al.
Publicado: (2021)

Feasibility of a multifaceted intervention to improve treatment initiation among patients diagnosed with TB using Xpert MTB/RIF testing in Uganda
por: Zawedde-Muyanja, Stella, et al.
Publicado: (2022)

Estimating the effect of pretreatment loss to follow up on TB associated mortality at public health facilities in Uganda
por: Zawedde-Muyanja, Stella, et al.
Publicado: (2020)

Acceptance and completion of rifapentine-based TB preventive therapy (3HP) among people living with HIV (PLHIV) in Kampala, Uganda—patient and health worker perspectives
por: Semitala, Fred C., et al.
Publicado: (2021)

Identifying barriers to and facilitators of tuberculosis contact investigation in Kampala, Uganda: a behavioral approach
por: Ayakaka, Irene, et al.
Publicado: (2017)

Implementation of Xpert MTB/RIF in Uganda: Missed Opportunities to Improve Diagnosis of Tuberculosis
por: Hanrahan, Colleen F., et al.
Publicado: (2016)

Economic Costs of Diabetes in the U.S. in 2012
Publicado: (2013)

Economic Costs of Diabetes in the U.S. in 2017
Publicado: (2018)

Impact of Xpert MTB/RIF Testing on Tuberculosis Management and Outcomes in Hospitalized Patients in Uganda
por: Yoon, Christina, et al.
Publicado: (2012)

Serologic Responses to Recombinant Pneumocystis jirovecii Major Surface Glycoprotein among Ugandan Patients with Respiratory Symptoms
por: Blount, Robert J., et al.
Publicado: (2012)

Implementation, feasibility, and acceptability of 99DOTS-based supervision of treatment for drug-susceptible TB in Uganda
por: Kiwanuka, Noah, et al.
Publicado: (2023)

Comparative assessment of the cost-effectiveness of Tuberculosis (TB) active case-finding interventions: A systematic analysis of TB REACH wave 5 projects
por: Gomes, Isabella, et al.
Publicado: (2022)

Multicomponent strategy with decentralised molecular testing for tuberculosis in Uganda: a cost and cost-effectiveness analysis
por: Thompson, Ryan R, et al.
Publicado: (2023)

Linking the health data system in the U.S.: Challenges to the benefits
por: Wu, Huixin, et al.
Publicado: (2017)

Implementation of New TB Screening Requirements for U.S.-Bound Immigrants and Refugees — 2007–2014
por: Posey, Drew L., et al.
Publicado: (2014)

Challenges with scale-up of GeneXpert MTB/RIF® in Uganda: a health systems perspective
por: Nalugwa, Talemwa, et al.
Publicado: (2020)

Public Health and Climate Benefits and Trade‐Offs of U.S. Vehicle Electrification
por: Peters, D. R., et al.
Publicado: (2020)

Benefits and costs of ecological restoration: Rapid assessment of changing ecosystem service values at a U.K. wetland
por: Peh, Kelvin S-H, et al.
Publicado: (2014)

Clinical and Radiographic Factors Do Not Accurately Diagnose Smear-Negative Tuberculosis in HIV-infected Inpatients in Uganda: A Cross-Sectional Study
por: Davis, J. Lucian, et al.
Publicado: (2010)

Containing U.S. health care costs: What bullet to bite?
por: Jencks, Stephen F., et al.
Publicado: (1992)

Cannot write session to /tmp/vufind_sessions/sess_isspr92r1pafo5h7fjcaqrp0go